Alaunos Therapeutics, Inc. Prepaid Expense and Other Assets, Noncurrent
Alaunos Therapeutics, Inc. (TCRT) had Prepaid Expense and Other Assets, Noncurrent of $776.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent · last filed 2026-08-14
- 2026-06-30: Prepaid Expense and Other Assets, Noncurrent $776.00K.
- 2026-03-31: Prepaid Expense and Other Assets, Noncurrent $831.00K.
- 2025-12-31: Prepaid Expense and Other Assets, Noncurrent $887.00K.
- 2025-09-30: Prepaid Expense and Other Assets, Noncurrent $942.00K.
| Period end | Prepaid Expense and Other Assets, Noncurrent |
|---|---|
| 2026-06-30 | $776.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $831.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $887.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $942.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $997.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.05M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |